Company intelligence / Profile preview

Boyuan Pharmaceutical

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Boyuan Pharmaceutical is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative small molecule drugs, primarily targeting immune-mediated inflammatory diseases and oncology. Based in Beijing, the company leverages a specialized drug discovery platform to design highly selective kinase inhibitors aimed at improving safety and therapeutic outcomes over existing treatments. Its lead candidate, BY1299, is a highly selective JAK1 inhibitor currently in Phase 2 clinical trials for atopic dermatitis and rheumatoid arthritis. The company is supported by leading healthcare investors including IDG Capital and BioTrack Capital. Boyuan continues to advance a robust pipeline of novel candidates through its integrated R&D capabilities.

Therapeutic areas: OncologyImmunologyDermatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Boyuan Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Boyuan Pharmaceutical.

Explore the full profile